Investing in the future

"XI Ventures" is a Russian investment company specializing in investing in projects in the field of living systems.

AgroBioTech 2020 was created in 2013 as a member of the Biopharmcluster «Northern» and with the main goal to implement in the Russian agricultural sector newest technologies to accelerate the process of creation of new species of plants.

The history of «VeinVis» began in June 2016, when the project team developed the first prototype of the device for the visualization of superficial veins. Soon, the first pilot batch was developed and handed over to the medical institutions of Moscow and the Moscow region for testing.

Personalized medicine and personalized approach to nutrition. The project started in August 2015. The company «Genetic diversity» is a member of the biopharmaceutical cluster "Northern" and collaborates with leading US and German organizations

«DNA Heritage» was established in February 2016 in collaboration with the MIPT Laboratory of Historical Genetics, Radiocarbon Analysis and Applied Physics.

Institute for Cellular and Molecular Technologies (ICMT) was established in 2013. ICMT is a member of the biopharmaceutical cluster "Northern" - association of the leading enterprises of the Russian pharmaceutical, biotech and medical industries, research institutes, hospitals and small innovative companies based at the Moscow Institute for physics and technology (MIPT).

The company "Innovative Neurosystems" in partnership with "Neurocom" develops an apparatus for correcting insomnia - "Sonia".
Externally, the device is a bracelet that is worn on the wrist during all night. The basics of the unit is the electrotherapeutic method of sleep normalization.

Interactive Neurotechnologies develops interactive solutions for non-drug methods of correction of behavior, diagnosis and treatment of psycho-neurological diseases and disorders, as well as recovery during rehabilitation period.

Integrated solutions for public defibrillation.
"CardiON" LLC was established in 2015. The company is member of the biopharmaceutical cluster "Northern" - association of the leading enterprises of the Russian pharmaceutical, biotech and medical industries, research institutes, hospitals and small innovative companies at the Moscow Institute for Physics and Technology (MIPT).

«Lekarex" was established in 2011. The company is a member of biopharmaceutical cluster "Northern" - association of the leading enterprises of the Russian pharmaceutical, biotech and medical industries, research institutes, hospitals and small innovative companies at the Moscow Institute for physics and technology (MIPT).

"NeuroTone" is an innovative, high-tech start-up in the NeuroNet category. The mission of the company includes the development of products that can enter the global market, representing high-tech Russian developments in Neurotechnology.

"New Health Technologies» develops medical devices for extracorporal life support. The company's founders have wide experience in the creation and commercialization of circulatory support systems, in particular worn circulatory support devices (AVK-N), which is currently being used successfully in Russian clinics.

DO YOU HAVE PROJECT?

Send order

Send order

attach presentation